(Q43047787)

12 November 2017

title

In-hospital peak glycemia and prognosis in STEMI patients without earlier known diabetes (English)

1 reference

12 November 2017

Chiara Lazzeri

1

1 reference

12 November 2017

Serafina Valente

2

1 reference

12 November 2017

Marco Chiostri

3

1 reference

12 November 2017

Claudio Picariello

4

1 reference

12 November 2017

Gian Franco Gensini

5

1 reference

12 November 2017

publication date

1 August 2010

1 reference

European Journal of Cardiovascular Prevention and Rehabilitation

12 November 2017

published in

1 reference

12 November 2017

volume

17

1 reference

12 November 2017

issue

4

1 reference

12 November 2017

page(s)

419-423

1 reference

Metabolic management of acute myocardial infarction comes to the fore and extends beyond control of hyperglycemia

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328335F26F

Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328335F26F

Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328335F26F

Glucose dysmetabolism and prognosis in critical illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328335F26F

Determinants of treatment strategies and survival in acute myocardial infarction: a population-based study in the Florence district, Italy: results of the acute myocardial infarction Florence registry (AMI-Florence).

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328335F26F

Optimal medical therapy with or without PCI for stable coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328335F26F

Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328335F26F

NT-proBNP on admission for early risk stratification in STEMI patients submitted to PCI. Relation with extension of STEMI and inflammatory markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328335F26F

Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328335F26F

Association between hyper- and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328335F26F

Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328335F26F

Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328335F26F

The Hyperglycemia: Intensive Insulin Infusion in Infarction (HI-5) study: a randomized controlled trial of insulin infusion therapy for myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328335F26F

Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328335F26F

Hyperglycaemia, in relation to sex, and mortality after acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328335F26F

Prevalence and characteristics of impaired glucose metabolism in patients referred to comprehensive cardiac rehabilitation: the DANSUK study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328335F26F

Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328335F26F

Lowering glucose to prevent adverse cardiovascular outcomes in a critical care setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328335F26F

Prognostic role of insulin resistance as assessed by homeostatic model assessment index in the acute phase of myocardial infarction in nondiabetic patients submitted to percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328335F26F

Glucose normalization and outcomes in patients with acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328335F26F

Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328335F26F

Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328335F26F

10.1097/HJR.0B013E328335F26F

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference